Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier Disruption for the Treatment of HighGrade Glioma in Patients Undergoing Standard Chemotherapy

IRB/UVA Tracking #
21802
Contact
Judith Beenhakker
Contact Email
Contact Phone
Cancer PI
Jason Sheehan
Status
OPEN TO ACCRUAL
Ages
Adult